Humanwell Healthcare Group Co

Humanwell Healthcare Group Co R&D per Employee

The R&D Spending per Employee of Humanwell Healthcare Group Co (600079.SS) as of Oct 30, 2026 is 93,385.17 CNY. In the previous year, R&D Spending per Employee was 91,509.60 CNY — a change of 2.05% (higher).

R&D per Employee

93,385.17CNY

YoY

2.05%

Last updated:

R&D Spending per Employee of Humanwell Healthcare Group Co is 2025 93,385.17 CNY. R&D Spending per Employee of Humanwell Healthcare Group Co was 2024 91,509.60 CNY. It decreases by 2.05% higher compared to the previous year.

The Humanwell Healthcare Group Co R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
30,126.01 CNY
Jan 1, 2019
36,786.83 CNY
Jan 1, 2020
47,762.89 CNY
Jan 1, 2021
50,433.67 CNY
Jan 1, 2022
60,165.26 CNY
Jan 1, 2023
90,973.37 CNY
Jan 1, 2024
91,509.60 CNY
Jan 1, 2025
93,385.17 CNY
The Humanwell Healthcare Group Co R&D per Employee history
YEARR&D per EmployeeYoY
93,385.17CNY+2.05%
91,509.60CNY+0.59%
90,973.37CNY+51.21%
60,165.26CNY+19.30%
50,433.67CNY+5.59%
47,762.89CNY+29.84%
36,786.83CNY+22.11%
30,126.01CNY+21.49%
24,796.20CNY-20.65%
31,247.74CNY+81.60%
17,207.01CNY+35.50%
12,698.92CNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Humanwell Healthcare Group Co Stock analysis

What does Humanwell Healthcare Group Co do? Humanwell Healthcare (Group) Co., Ltd. generates revenue through the research and development, production, and sale of a diverse portfolio of medical products. The company’s offerings are categorized into chemical drugs, chemical raw material medicines, traditional Chinese medicines, biological medicines, and others, alongside the provision of medical instruments. This broad product range allows the firm to serve various healthcare needs across its operational scope. The company distributes its products in both domestic market and to overseas markets, indicating a dual-channel sales strategy that captures value from local and international customers. By engaging in the full lifecycle of medical product creation, from R&D to final sale, Humanwell Healthcare (Group) Co., Ltd. monetizes its extensive capabilities and wide distribution network to drive financial performance. Humanwell Healthcare Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Humanwell Healthcare Group Co stock

R&D Spending per Employee of Humanwell Healthcare Group Co is 93,385.17 CNY in 2025.

R&D Spending per Employee of Humanwell Healthcare Group Co changed from 91,509.60 CNY to 93,385.17 CNY, representing a 2.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Humanwell Healthcare Group Co since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Humanwell Healthcare Group Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Workforce — Humanwell Healthcare Group Co

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — Humanwell Healthcare Group Co